Position in AVBP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$23,043,319
+$7,740,804 QoQ
Shares Held
663,308
0.0% QoQ
Ownership
1.35%
of shares outstanding
% of Portfolio
1.93%
of 13F equity value
Holder Rank
#18
of 158 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVBP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HSG Holding Ltd holds $70,756,776 across 6 Biotechnology names. AVBP ranks #2 (32.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GYRE |
Gyre Therapeutics, Inc.
|
3,750,299 | $24,714,470 | |
| 2 | AVBP |
ArriVent BioPharma, Inc.
This page
|
663,308 | $23,043,319 | |
| 3 | GPCR |
Structure Therapeutics Inc.
|
266,062 | $14,279,547 | |
| 4 | ADAG |
Adagene Inc.
|
1,343,364 | $5,642,128 | |
| 5 | LYEL |
Lyell Immunopharma, Inc.
|
152,299 | $2,139,800 | |
| 6 | BRNS |
Barinthus Biotherapeutics plc.
|
1,420,473 | $937,512 |
All Filings in AVBP
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,043,319 | 663,308 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $15,302,515 | 663,308 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,345,756 | 663,308 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $12,238,032 | 663,308 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $14,440,215 | 663,308 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,264,564 | 663,308 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $17,670,525 | 663,308 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $15,587,738 | 663,308 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $12,304,363 | 663,308 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $11,846,680 | 663,308 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||